Inovio Pharmaceuticals, Inc. · Brief

Next report

9 days

Nov 9 · after closeest.Q3 FY26

Expected move

No implied move.

—≥ implied

Q2 FY26±32.2%▲+16.90%×0.52

quarterimplied−35%0+35%realized×

Q2 FY26±32.2%▲+16.90%×0.52

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 9 report · est.

Bull2

105managers reporting a position in the latest quarterly filings13F · Jun 30 '26

+6.72%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2

100.00%of revenue from the largest disclosed customer ApolloBio CorporationSEC filings

7 of 20of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

INO report session

No linked exposure.

Oct 26impliedImplied move: ±68.4% into Nov 9 earnings (Oct 26 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.